273 related articles for article (PubMed ID: 17018631)
21. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
22. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
[TBL] [Abstract][Full Text] [Related]
23. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
25. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Haraguchi N; Inoue H; Murayama S; Mori M
Int J Oncol; 2006 Mar; 28(3):705-13. PubMed ID: 16465376
[TBL] [Abstract][Full Text] [Related]
26. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
27. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].
Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732
[TBL] [Abstract][Full Text] [Related]
28. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
32. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers.
Sato N; Fukushima N; Chang R; Matsubayashi H; Goggins M
Gastroenterology; 2006 Feb; 130(2):548-65. PubMed ID: 16472607
[TBL] [Abstract][Full Text] [Related]
33. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.
Greco E; Basso D; Fadi E; Padoan A; Fogar P; Zambon CF; Navaglia F; Bozzato D; Moz S; Pedrazzoli S; Plebani M
Pancreas; 2010 Jul; 39(5):662-8. PubMed ID: 20562578
[TBL] [Abstract][Full Text] [Related]
34. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B
Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
36. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
37. Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity.
Suzuki K; Nagasawa H; Uto Y; Sugimoto Y; Noguchi K; Wakida M; Wierzba K; Terada T; Asao T; Yamada Y; Kitazato K; Hori H
Bioorg Med Chem; 2005 Jun; 13(12):4014-21. PubMed ID: 15911314
[TBL] [Abstract][Full Text] [Related]
38. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
39. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]